EUVIMEDEUVIMED entdecken
Open Access

Decreasing Incidence of Chemosensory Changes by COVID‐19 Variant

Daniel H Coelho iD, Evan R Reiter, Evan French, Richard M Costanzo

Otolaryngology–Head and Neck Surgery · 2023

DOI: 10.1177/01945998221097656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2023. Verfasst von Daniel H Coelho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: COVID-19, Olfaction Disorders. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, Medarva Foundation, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anecdotal clinical observation suggests that rates of chemosensory dysfunction associated with COVID‐19 infection may be decreasing. To investigate, the National COVID Cohort Collaborative database was queried for all patients with and without smell and taste loss within 2 weeks of COVID‐19 diagnosis. Six‐week periods of peak variant prevalence were selected by using CoVariants.org for analysis. Of 3,678,214 patients with COVID‐19 in the database, 616,318 met inclusion criteria during the time intervals of interest, with 3431 having an associated smell or taste disturbance diagnosis. With the initial/untyped variant set as the baseline, the odds ratios for alpha, delta, and omicron (December 27, 2021–February 7, 2022) were 0.50 (95% CI, 0.45‐0.55; P < .0001), 0.44 (95% CI, 0.41‐0.48; P < .0001), and 0.17 (95% CI, 0.15‐0.18; P < .0001), respectively. These data strongly support the clinical observation that patients infected with more recent variants are at a significantly lower risk of developing associated chemosensory loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Olfaction DisordersHumansSARS-CoV-2IncidenceCOVID-19 Testing

Stichwörter der Autor:innen

COVIDNC3alphadeltaomicronsmelltaste

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID-Profile: Daniel H Coelho

Förderung

  • NCATS NIH HHS
  • Medarva Foundation
  • National Center for Advancing Translational Sciences

Zitieren

APA

Coelho, D. H., Reiter, E. R., French, E., & Costanzo, R. M. (2023). Decreasing Incidence of Chemosensory Changes by COVID‐19 Variant. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1177/01945998221097656

Vancouver

Coelho DH, Reiter ER, French E, Costanzo RM. Decreasing Incidence of Chemosensory Changes by COVID‐19 Variant. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1177/01945998221097656

BibTeX
@article{Coelho2023,
  author = {Coelho, Daniel H and Reiter, Evan R and French, Evan and Costanzo, Richard M},
  title = {Decreasing Incidence of Chemosensory Changes by COVID‐19 Variant},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2023},
  doi = {10.1177/01945998221097656}
}
Kostenlos starten →